Abstract:This study intended to investigate the expression of the ZEB1 and E-cadherin proteins in lung squamous cell carcinoma (LSCC) tissues and to examine the clinicopathological correlation between protein levels and LSCC. RT-PCR and Western blot were used to examine the expression of ZEB1 and E-cadherin mRNAs and proteins in LSCC tissues as well as in adjacent normal tissues, and then analyze the relationship between the clinicopathological characteristics and the expression changes of ZEB1 and E-cadherin mRNAs in LSCC. In addition, RNAi was used to knockdown the expression of the ZEB1 gene in Human HCC827 cells; subsequently, changes in the invasive ability of the resultant cells were studied. The positive rates of ZEB1 and E-cadherin mRNAs in LSCC tissues were 69.2 and 38.5 %, respectively. They differed significantly from the corresponding positive rates in the adjacent normal lung tissues (15.4 and 80.8 %, p < 0.05). There was a negative correlation between the protein levels of ZEB1 and E-cadherin in LSCC tissues ( r = -0.714, p < 0.001); in addition, it was found that ZEB1 protein expression in LSCC tissues was significantly higher than that in the neighboring normal lung tissues ( p < 0.05), and its expression was also significantly higher in patients with lymph node metastases and distant metastases compared to those patients without metastatic disease ( p < 0.05). On the contrary, E-cadherin expression was significantly lower in LSCC tissues than that in the neighboring normal tissue ( p < 0.05). It was lower in patients with lymph node metastasis and distant metastasis compared to patients without metastatic disease ( p < 0.05). However, the expression of ZEB1 and E-cadherin was independent of gender, age, tumor size, or tumor differentiation level ( p > 0.05). Transfection of ZEB1 siRNA into HCC827 cells significantly reduced the ZEB1 protein level ( p < 0.01) and significantly elevated E-cadherin levels ( p < 0.01). Moreover, significantly less ZEB1 siRNA-transfected cells migrated through Transwell chambers in the LSCC tissue than that in the control groups (untransfected or transfected with control siRNA, p < 0.01). The expression of the ZEB1 gene in LSCC tissues is downregulated with the expression of E-cadherin. On the other hand, the expression of siRNA against ZEB1 promotes E-cadherin expression and suppresses the invasive ability conferred by E-cadherin. In conclusion, our data suggested that overexpression of the ZEB1 gene is possibly associated with the occurrence, development, invasion of LSCC.

The Expression of ZNF217 in Human Hepatocellular Carcinoma and Its Role in Tumor Invasion

Zinc Finger Protein 296 Promotes Hepatocellular Carcinoma Progression Via Intervening Interaction Between Macrophages and B Cells.

The Coordination Between ZNF217 and LSD1 Contributes to Hepatocellular Carcinoma Progress and is Negatively Regulated by Mir-101.

[Expression of ZNF207 in Hepatocellular Carcinoma and Its Significance].

ZKSCAN3 Drives Tumor Metastasis Via Integrin Β4/fak/akt Mediated Epithelial–mesenchymal Transition in Hepatocellular Carcinoma

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Retraction Note: Upregulation of Long Noncoding RNA ZEB1-AS1 Promotes Tumor Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma

Expression of zinc finger protein 217 in non-small cell lung cancer and clinical significance

ZNF143-mediated Upregulation of MEX3C Promotes Hepatocellular Carcinoma Progression

Expression of zinc finger 23 gene in human hepatocellular carcinoma.

Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma

Expression of ZEB-1 in Hepatocellular Carcinoma Tissues and Its Significance

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma

ZFC3H1 as an Indicator of Poor Prognosis in Hepatocellular Carcinoma: Bioinformatic Analysis and Experimental Verification

Up-regulation of RNF187 induces hepatocellular carcinoma cell epithelial to mesenchymal transitions.

Knockdown of ZNF233 Suppresses Hepatocellular Carcinoma Cell Proliferation and Tumorigenesis.

ZNF667 Serves As a Putative Oncogene in Human Hepatocellular Carcinoma

Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma.

Downregulation of ZEB2-AS1 Decreased Tumor Growth and Metastasis in Hepatocellular Carcinoma

Ezrin Expression of Hepatocellular Carcinoma and Its Relationship with Adhesion,Invasion and Thrombosis in Portal Vein of Tumor

ZNF281 Facilitates the Invasion of Cervical Cancer Cell Both In Vivo and In Vitro †